These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12794061)

  • 1. The role of neural inflammation in asthma and chronic obstructive pulmonary disease.
    Joos GF; De Swert KO; Schelfhout V; Pauwels RA
    Ann N Y Acad Sci; 2003 May; 992():218-30. PubMed ID: 12794061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Airway inflammation and tachykinins: prospects for the development of tachykinin receptor antagonists.
    Joos GF; De Swert KO; Pauwels RA
    Eur J Pharmacol; 2001 Oct; 429(1-3):239-50. PubMed ID: 11698044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurokinin-1 receptor mediates stress-exacerbated allergic airway inflammation and airway hyperresponsiveness in mice.
    Joachim RA; Sagach V; Quarcoo D; Dinh QT; Arck PC; Klapp BF
    Psychosom Med; 2004; 66(4):564-71. PubMed ID: 15272104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dichotomy between neurokinin receptor actions in modulating allergic airway responses in an animal model of helper T cell type 2 cytokine-associated inflammation.
    Maghni K; Taha R; Afif W; Hamid Q; Martin JG
    Am J Respir Crit Care Med; 2000 Sep; 162(3 Pt 1):1068-74. PubMed ID: 10988132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of two novel tachykinin antagonists, FK224 and FK888, on neurogenic airway plasma exudation, bronchoconstriction and systemic hypotension in guinea-pigs in vivo.
    Hirayama Y; Lei YH; Barnes PJ; Rogers DF
    Br J Pharmacol; 1993 Mar; 108(3):844-51. PubMed ID: 7682142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of inflammatory cell recruitment by the tachykinin NK(3)-receptor antagonist, SR 142801, in a murine model of asthma.
    Nénan S; Germain N; Lagente V; Emonds-Alt X; Advenier C; Boichot E
    Eur J Pharmacol; 2001 Jun; 421(3):201-5. PubMed ID: 11516437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extending the understanding of sensory neuropeptides.
    De Swert KO; Joos GF
    Eur J Pharmacol; 2006 Mar; 533(1-3):171-81. PubMed ID: 16464447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory cells as source of tachykinin-induced mucus secretion in chronic bronchitis.
    Springer J; Groneberg DA; Pregla R; Fischer A
    Regul Pept; 2005 Jan; 124(1-3):195-201. PubMed ID: 15544859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Airway sensory nerve and tachykinins in asthma and COPD].
    Dinh QT; Klapp BF; Fischer A
    Pneumologie; 2006 Feb; 60(2):80-5. PubMed ID: 16463247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Important roles of tachykinins in the development of allergic nasal hyperresponsiveness in guinea-pigs.
    Nabe T; Tsuzuike N; Ohtani Y; Mizutani N; Watanabe S; Fujii M; Yoshimura M; Nagasawa M; Kohno S
    Clin Exp Allergy; 2009 Jan; 39(1):138-46. PubMed ID: 18778270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tachykinins in the lungs.
    Chapman RW; Hey JA; McLeod R; Minnicozzi M; Rizzo C
    Drug News Perspect; 1998 Oct; 11(8):480-9. PubMed ID: 15616676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined NK(1)and NK(2)receptor antagonists on the bronchoconstrictor response to NKA in dogs.
    Chapman RW; Schilling A; Ng K; Nardo C; Kreutner W; Young S
    Pulm Pharmacol Ther; 1999; 12(4):261-6. PubMed ID: 10500006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of selective tachykinin-receptor antagonists on tachykinin-induced airway mucus secretion in the rat.
    Wagner U; Fehmann H; Bredenbröker D; Klüber D; Lange A; Wichert P
    Neuropeptides; 1999 Feb; 33(1):55-61. PubMed ID: 10657472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of inhaled FK224, a tachykinin NK-1 and NK-2 receptor antagonist, on neurokinin A-induced bronchoconstriction in asthmatics.
    Joos GF; Van Schoor J; Kips JC; Pauwels RA
    Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1781-4. PubMed ID: 8665034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratracheal Administration of Mesenchymal Stem Cells Modulates Tachykinin System, Suppresses Airway Remodeling and Reduces Airway Hyperresponsiveness in an Animal Model.
    Urbanek K; De Angelis A; Spaziano G; Piegari E; Matteis M; Cappetta D; Esposito G; Russo R; Tartaglione G; De Palma R; Rossi F; D'Agostino B
    PLoS One; 2016; 11(7):e0158746. PubMed ID: 27434719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensory neuropeptides and the human lower airways: present state and future directions.
    Joos GF; Germonpre PR; Kips JC; Peleman RA; Pauwels RA
    Eur Respir J; 1994 Jun; 7(6):1161-71. PubMed ID: 7925887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tachykinin NK3 and NK1 receptor activation elicits secretion from porcine airway submucosal glands.
    Phillips JE; Hey JA; Corboz MR
    Br J Pharmacol; 2003 Jan; 138(1):254-60. PubMed ID: 12522097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic neurokinin-1 receptor antagonism fails to ameliorate clinical signs, airway hyper-responsiveness or airway eosinophilia in an experimental model of feline asthma.
    Grobman M; Graham A; Outi H; Dodam JR; Reinero CR
    J Feline Med Surg; 2016 Apr; 18(4):273-9. PubMed ID: 25964466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of nitric oxide and septide-insensitive NK(1) receptors in bronchoconstriction induced by aerosolised neurokinin A in guinea-pigs.
    Ricciardolo FL; Trevisani M; Geppetti P; Nadel JA; Amadesi S; Bertrand C
    Br J Pharmacol; 2000 Mar; 129(5):915-20. PubMed ID: 10696090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the tachykinin NK1 receptor in airway changes in a mouse model of allergic asthma.
    De Swert KO; Tournoy KG; Joos GF; Pauwels RA
    J Allergy Clin Immunol; 2004 Jun; 113(6):1093-9. PubMed ID: 15208590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.